BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38400734)

  • 1. Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke.
    Vollmuth C; Fiessler C; Montellano FA; Kollikowski AM; Essig F; Oeckl P; Barba L; Steinacker P; Schulz C; Ungethüm K; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Otto M; Neugebauer H
    Eur Stroke J; 2024 Feb; ():23969873241234436. PubMed ID: 38400734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
    Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
    Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients.
    Ferrari F; Rossi D; Ricciardi A; Morasso C; Brambilla L; Albasini S; Vanna R; Fassio C; Begenisic T; Loi M; Bossi D; Zaliani A; Alberici E; Lisi C; Morotti A; Cavallini A; Mazzacane F; Nardone A; Corsi F; Truffi M
    J Cereb Blood Flow Metab; 2023 Sep; 43(9):1601-1611. PubMed ID: 37113060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
    Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
    Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early plasma biomarker dynamic profiles are associated with acute ischemic stroke outcomes.
    Correia M; Silva I; Gabriel D; Simrén J; Carneiro A; Ribeiro S; Dória HM; Varela R; Aires A; Minta K; Antunes R; Felgueiras R; Castro P; Blenow K; Magalhães R; Zetterberg H; Maia LF
    Eur J Neurol; 2022 Jun; 29(6):1630-1642. PubMed ID: 35124870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.
    Uphaus T; Bittner S; Gröschel S; Steffen F; Muthuraman M; Wasser K; Weber-Krüger M; Zipp F; Wachter R; Gröschel K
    Stroke; 2019 Nov; 50(11):3077-3084. PubMed ID: 31537188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study.
    Verberk IMW; Laarhuis MB; van den Bosch KA; Ebenau JL; van Leeuwenstijn M; Prins ND; Scheltens P; Teunissen CE; van der Flier WM
    Lancet Healthy Longev; 2021 Feb; 2(2):e87-e95. PubMed ID: 36098162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial fibrillary acidic protein as a prognostic marker of acute ischemic stroke.
    Liu G; Geng J
    Hum Exp Toxicol; 2018 Oct; 37(10):1048-1053. PubMed ID: 29308673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
    Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
    Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression.
    Hviid CVB; Benros ME; Krogh J; Nordentoft M; Christensen SH
    J Affect Disord; 2023 Oct; 338():341-348. PubMed ID: 37336248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
    Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
    J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke.
    Tiedt S; Duering M; Barro C; Kaya AG; Boeck J; Bode FJ; Klein M; Dorn F; Gesierich B; Kellert L; Ertl-Wagner B; Goertler MW; Petzold GC; Kuhle J; Wollenweber FA; Peters N; Dichgans M
    Neurology; 2018 Oct; 91(14):e1338-e1347. PubMed ID: 30217937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
    Lin X; Lu T; Deng H; Liu C; Yang Y; Chen T; Qin Y; Xie X; Xie Z; Liu M; Ouyang M; Li S; Song Y; Zhong N; Qiu W; Zhou C
    J Neurol; 2022 Feb; 269(2):815-823. PubMed ID: 34283286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
    Pauwels A; Van Schependom J; Devolder L; Van Remoortel A; Nagels G; Bjerke M; D'hooghe MB
    Mult Scler; 2022 Oct; 28(11):1685-1696. PubMed ID: 36059263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neurofilament light chain level predicts outcomes in stroke patients receiving endovascular thrombectomy.
    Chen CH; Chu HJ; Hwang YT; Lin YH; Lee CW; Tang SC; Jeng JS
    J Neuroinflammation; 2021 Sep; 18(1):195. PubMed ID: 34511123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
    Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
    Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Blood-Based Brain Injury Biomarker Concentrations With Outcomes After Pediatric Cardiac Arrest.
    Fink EL; Kochanek PM; Panigrahy A; Beers SR; Berger RP; Bayir H; Pineda J; Newth C; Topjian AA; Press CA; Maddux AB; Willyerd F; Hunt EA; Siems A; Chung MG; Smith L; Wenger J; Doughty L; Diddle JW; Patregnani J; Piantino J; Walson KH; Balakrishnan B; Meyer MT; Friess S; Maloney D; Rubin P; Haller TL; Treble-Barna A; Wang C; Clark RRSB; Fabio A;
    JAMA Netw Open; 2022 Sep; 5(9):e2230518. PubMed ID: 36074465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis.
    Camara-Lemarroy C; Silva C; Gohill J; Yong VW; Koch M
    Eur J Neurol; 2023 Jan; 30(1):187-194. PubMed ID: 36214614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.